Organizer
Agilent Technologies
Agilent Technologies
Analytical scientists and clinical researchers worldwide rely on Agilent to help fulfill their most complex laboratory demands. Our instruments, software, services and consumables address the full range of scientific and laboratory management needs.
Tags
LC/MS
LC/MS/MS
LC/QQQ
OMICS
LinkedIn Logo

Absolute and Relative Quantitation for Targeted Metabolomics and Lipidomics

RECORD | Already taken place Tu, 25.5.2021
In this presentation we show absolute quantitation of fragile metabolites using the dMRM method and incorporating isotope dilution mass spectrometry (IDMS).
Go to the webinar
Agilent Technologies: Absolute and Relative Quantitation for Targeted Metabolomics and Lipidomics
Agilent Technologies: Absolute and Relative Quantitation for Targeted Metabolomics and Lipidomics

The ultimate goal of targeted metabolomics and lipidomics is to report absolute metabolite and lipid concentrations. The Agilent Metabolomics dMRM Database and Method is a supported solution for 219 central carbon metabolites in negative ion mode. It is a fully tested rugged method that provides incredibly stable retention times across large numbers of samples with excellent inter-day and extended (over 4000 biological samples) retention-time reproducibility.

IDMS gets rid of Ionization suppression effects as well as any bias from sample preparation and instrument conditions. The only downside is the cost and availability of isotopically labeled internal standards, especially in an assay with 219 metabolites. We have circumvented the cost of purchasing individual internal standards by using 13C incorporated yeast from Cambridge Isotope Labs. These cells are grown in 13C enriched media and the resulting metabolites in the extract have >99% isotopic enrichment. Using this technique, we show linearity for fragile metabolites over six orders of magnitude ranging in most cases from attomole to nanomoles concentrations on column.

We will also present the method and results for targeted lipidomics with the use of deuterated internal standards that covers a wide range of lipid classes.

For Research Use Only. Not for use in diagnostic procedures.

Presenter: Sheher Banu Mohsin, PhD (Senior Applications Scientist, Agilent Technologies, Inc.)

Sheher Mohsin is a senior applications scientist at Agilent Technologies. She received her Ph. D in physical chemistry from the University of Illinois and an MBA from Rockhurst University. She started her career at the US Environmental Protection Agency working on dioxin analysis with high resolution mass spectrometers. She later joined Bayer and worked in the special analysis lab using mass spectrometry to solve problems in synthesis, impurity determination and submission of final product impurity profile to regulatory agencies. Sheher’s current focus is on lipidomics using GC, LC and SFC separations and mass spectrometry. Sheher collaborates with academic and government researchers working on complex problems to come up with innovative, simplified workflows using the latest tools in separation and mass spectrometry.

Agilent Technologies
LinkedIn Logo
 

Related content

Comprehensive and Robust Analysis of Ultrashort- to Long-Chain PFAS, PAE, OPE, and PAH

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Agilent Technologies, Plasmion
Industries
Environmental

UPLC™ Separation of Fifteen Bisphenols Using a Waters Acquity™ Biphenyl RP Column with MaxPeak™ Premier Technology and UV Detection

Applications
| 2026 | Waters
Instrumentation
Consumables, LC columns, HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma

Achieving Low‑ppb Bisphenol Quantitation with the Agilent InfinityLab Pro iQ Mass Detector

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Materials Testing

ECL detection of fentanyl

Applications
| 2026 | Metrohm
Instrumentation
Electrochemistry
Manufacturer
Metrohm
Industries
Forensics

Early-stage drug metabolite quantitation without radiolabels

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Metabolomics
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike